Invesco India Pharma and Healthcare Fund - Regular Plan - Growth

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 10.07 ↑ 0.3%
[as on 21 September, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Invesco India Pharma and Healthcare Fund - Regular Plan - Growth and its peers as on 21 September, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Invesco India Pharma and Healthcare Fund - Regular Plan - Growth- 0.3% 0.8%-------
Nippon India Banking & Financial Services Fund-Growth Plan-Growth Option -3.44% -0.19% -0.02% -1.79% -0.87% 1.85% 11.34% 12.6% 13.32% 12.13%
Nippon India Pharma Fund-Growth Plan-Growth Option 13.31% 0.87% 1.7% 0.93% 6.32% 10.15% 18.34% 13.13% 21.93% 14.7%
Nippon India Power & Infra Fund-Growth Plan -Growth Option 8.53% 0.32% -0% -2.48% -2.7% 6.33% 18% 20.06% 22% 16.94%
DSP Healthcare Fund - Regular Plan - Growth 17.55% 0.67% 1.82% 0.61% 11.63% 14.85% 21.22% 14.48% 23.98%-
DSP Banking & Financial Services Fund - Regular - Growth 3.81% -0.26% -0.42% -2.57% 1.89% 10.72%----

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns----------

Discrete returns (monthly)

MonthNov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026
Returns----------

NAV history

Invesco India Pharma and Healthcare Fund - Regular Plan - Growth - 30 days NAV (Net asset value) history

DateNAV% change
21 September, 202610.07 0.3%
18 September, 202610.04 0.9%
17 September, 20269.95 0.71%
16 September, 20269.88 -0.1%
15 September, 20269.89 -1%
11 September, 20269.99 -0.2%
10 September, 202610.01

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Invesco India Pharma and Healthcare Fund - Regular Plan - Growth?
    The latest NAV of Invesco India Pharma and Healthcare Fund - Regular Plan - Growth is 10.07 as on 21 September, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Invesco India Pharma and Healthcare Fund - Regular Plan - Growth?
    Invesco India Pharma and Healthcare Fund - Regular Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.